Beryl Drugs Shareholders Approve Shailendra Pathak Director Regularisation

Beryl Drugs shareholders approved the regularisation of Mr. Shailendra Pathak as Whole-Time Director for 5 years at an EGM held on May 11, 2026.
Mr. Pathak was initially appointed by the board on January 3, 2026, and brings over 35 years of pharmaceutical industry experience to the role.
His remuneration includes a fixed salary of ₹1.25 lakh per month plus sales-based commission of 0.25% on existing and 0.50% on additional sales.
The disclosure is made pursuant to SEBI Listing Regulations to inform the exchange about this key management appointment and shareholder approval.